Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

Develops and markets medications used in the fields of neurology, dermatology and infectious diseases. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

IPO
N/A

$1.5b

Post IPO Debt
N/A

$900m

Post IPO Debt
N/A

$1.0b

Post IPO Debt
N/A

$3.3b

Post IPO Debt
N/A

$200m

Post IPO Debt
N/A

$1.5b

Post IPO Debt
Total Funding-

Recent News about Valeant Pharmaceuticals International

Edit
More about Valeant Pharmaceuticals Internationalinfo icon
Edit

Bausch Health Companies Inc. operates as a global leader in the healthcare sector, focusing on pharmaceuticals, medical devices, and over-the-counter consumer health products. Serving a diverse range of clients, including hospitals, healthcare providers, and individual consumers, Bausch Health aims to improve lives through its extensive portfolio of products. The company operates in various markets worldwide, leveraging its broad distribution network to reach over 150 million people daily. Bausch Health's business model revolves around the development, manufacturing, and marketing of its healthcare products, generating revenue through direct sales and partnerships with healthcare institutions. The company continues to gain momentum, positioning itself as a turnaround opportunity with significant growth potential.

Keywords: pharmaceuticals, medical devices, consumer health, global leader, healthcare products, hospitals, healthcare providers, individual consumers, distribution network, turnaround opportunity.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Valeant Pharmaceuticals International

Edit
Bausch & Lomb
ACQUISITION by Valeant Pharmaceuticals International May 2013
LipoSonix
ACQUISITION by Valeant Pharmaceuticals International Jun 2008
Private Formula International Holdings
ACQUISITION by Valeant Pharmaceuticals International Sep 2009
Revance Therapeutics
ACQUISITION by Crown Laboratories Aug 2024
Aton Pharma
ACQUISITION by Valeant Pharmaceuticals International May 2010
PreCision Dermatology
ACQUISITION by Valeant Pharmaceuticals International Feb 2014
Sprout Pharmaceuticals
ACQUISITION by Valeant Pharmaceuticals International Aug 2015
DermTech
ACQUISITION Sep 2024
Ascent Pediatrics
ACQUISITION by Valeant Pharmaceuticals International Nov 2001
Xcel Pharmaceuticals
ACQUISITION by Valeant Pharmaceuticals International Feb 2005
View 4 more